PFIZER INC Disposal Group, Including Discontinued Operation, Revenue
PFIZER INC (PFE) reported Disposal Group, Including Discontinued Operation, Revenue of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2016-02-29
- PFIZER INC disposal group, including discontinued operation, revenue for the quarter ending 2014-06-29 was $0.00, a 100.00% decline year-over-year.
- PFIZER INC disposal group, including discontinued operation, revenue for the quarter ending 2014-03-30 was $0.00, a 100.00% decline year-over-year.
- PFIZER INC disposal group, including discontinued operation, revenue for the quarter ending 2013-06-30 was $1.11B, a 91.39% increase year-over-year.
- PFIZER INC disposal group, including discontinued operation, revenue for the quarter ending 2013-03-31 was $1.09B, a 109.42% increase year-over-year.
- PFIZER INC disposal group, including discontinued operation, revenue for fiscal 2015 was $0.00.
- PFIZER INC disposal group, including discontinued operation, revenue for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- PFIZER INC disposal group, including discontinued operation, revenue for fiscal 2013 was $2.20B, a 66.59% decline from fiscal 2012.
- PFIZER INC disposal group, including discontinued operation, revenue for fiscal 2012 was $6.59B, a 4.49% decline from fiscal 2011.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 12 month | Disposal Group, Including Discontinued Operation, Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-29 | ||||
| 2014-12-31 | $0.00 10-K · filed 2016-02-29 | ||||
| 2014-06-29 | $0.00 10-Q · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 | |||
| 2014-03-30 | $0.00 10-Q · filed 2014-05-08 | ||||
| 2013-12-31 | $2.20B 10-K · filed 2016-02-29 | ||||
| 2013-06-30 | $1.11B 10-Q · filed 2014-08-07 | $2.20B 10-Q · filed 2014-08-07 | $7.12B derived: sum of 3 quarters · filed 2015-02-27 | $7.69B derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-03-31 | $1.09B 10-Q · filed 2014-05-08 | $6.01B derived: sum of 2 quarters · filed 2015-02-27 | $6.58B derived: sum of 3 quarters · filed 2015-02-27 | $7.16B derived: sum of 4 quarters · filed 2015-02-27 | |
| 2012-12-31 | $4.92B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $5.49B derived: sum of 2 quarters · filed 2015-02-27 | $6.07B derived: sum of 3 quarters · filed 2015-02-27 | $6.59B 10-K · filed 2015-02-27 | $2.26B 10-K · filed 2013-02-28 |
| 2012-09-30 | $564.00M 10-Q · filed 2012-11-09 | $1.15B derived: sum of 2 quarters · filed 2012-11-09 | $1.67B 10-Q · filed 2012-11-09 | $6.49B derived: sum of 4 quarters · filed 2014-02-28 | |
| 2012-07-01 | $581.00M 10-Q · filed 2012-08-09 | $1.10B 10-Q · filed 2012-08-09 | $5.93B derived: sum of 3 quarters · filed 2014-02-28 | $6.63B derived: sum of 4 quarters · filed 2014-02-28 | |
| 2012-04-01 | $520.00M 10-Q · filed 2013-05-10 | $5.35B derived: sum of 2 quarters · filed 2014-02-28 | $6.05B derived: sum of 3 quarters · filed 2014-02-28 | $6.76B derived: sum of 4 quarters · filed 2014-02-28 | |
| 2011-12-31 | $4.83B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $5.53B derived: sum of 2 quarters · filed 2014-02-28 | $6.24B derived: sum of 3 quarters · filed 2014-02-28 | $6.90B 10-K · filed 2014-02-28 | $2.67B 10-K · filed 2013-02-28 |
| 2011-10-02 | $699.00M 10-Q · filed 2012-11-09 | $1.41B derived: sum of 2 quarters · filed 2012-11-09 | $2.07B 10-Q · filed 2012-11-09 | ||
| 2011-07-03 | $714.00M 10-Q · filed 2012-08-09 | $1.37B 10-Q · filed 2012-08-09 | |||
| 2011-04-03 | $177.00M 10-Q · filed 2011-05-12 | ||||
| 2010-12-31 | $2.64B 10-K · filed 2013-02-28 | ||||
| 2010-04-04 | $174.00M 10-Q · filed 2011-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |